Products for Research Use Only
RegisterLogin

Smo Antagonist, SA9

CAT: 0026-2155-5Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0026-2155-5Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SA9 inhibits Hh pathway by interacting directly with Smo. It inhibits SAG (Smoothened agonist) activation of Hh signaling in Shh-LIGHT 2 cells (IC₅₀ = 19 µM). Induces the localization of Smo to cilia in ASZ1 cells, but not in IMCD3 cells. Also treatment of Ptch1-/- MEFs with SA9 suppresses the β-galactosidase activity (IC₅₀ = 1.0 µM) and inhibits the expression of Gli1 and Ptch1 in ASZ1 cells.
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
24months

Related Products

CatalogName
2154-2Smo Antagonist, SA1
2159-5Smo Antagonist, SA10
2154-5Smo Antagonist, SA1
2159-2Smo Antagonist, SA10
1939-1Smo Agonist, SAG
1939-5Smo Agonist, SAG
A1058-100SMO Antibody (Center)
2801-1Smo agonist, SAG dihydrochloride
2801-5Smo agonist, SAG dihydrochloride
1979-10PPARγ Antagonist, G3335

Alternative Products

CatalogName
TBI2441-250MGPranlukast, Leukotriene CysLT1 antagonist; GPR17 antagonist
TBI2597-50MGMontelukast, Leukotriene CysLT1 antagonist; GPR17 antagonist
cyt-538-01chGH Antagonist
cyt-215-01oGH Antagonist
4031352.0500VIP Antagonist
H-8650.0005PDGF Antagonist
JLB39188-01Vasopressin antagonist
254641Antagonist G
T36127-01TNF-α Antagonist
sc-221406BCCR4 Antagonist

Popular Products